NewGenIvf (NIVFW) Return on Sales (2024 - 2025)
NewGenIvf (NIVFW) reported Return on Sales of 0.05% for Q4 2025, down 5.0% year-over-year from 0.06% in Q4 2024, and down 141.48% quarter-over-quarter from 0.13% in Q3 2025.
NewGenIvf (NIVFW) Return on Sales (2024 - 2025) Analysis & Trends
NewGenIvf (NIVFW) has 2 years of Return on Sales data on file, last reported at 0.05% in Q4 2025.
- Return on Sales for Q4 2025 came in at 0.05%, down 5.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.02% (changed N/A YoY), and the FY2025 annual result was 0.02%, up 2.0% from the prior year.
- Return on Sales slipped to 0.05% in Q4 2025 per NIVFW's latest filing, from 0.13% in the prior quarter.
- Over five years, Return on Sales peaked at 0.13% in Q3 2025 and troughed at 0.05% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | 0.00% |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 0.00% |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | 0.00% |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | 0.00% |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 0.00% |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | 0.00% |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | 0.03% |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | 0.00% |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | 0.00% |
| 10 | NewGenIvf | - | - | 524,025.00 | -0.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.05% |
| Sep 30, 2025 | 0.13% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |